Home › Alopecia Areata › Maryland
Alopecia Areata clinical trials in Maryland
5 studies for Alopecia Areata are looking for participants at sites in Maryland.
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Johns Hopkins University, Baltimore
- Dermatology and Skin Cancer Specialists, LLC, Rockville
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 18, 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Cutaneous Translational Research Program (CTReP), Baltimore
- Johns Hopkins Hospital Investigational Drug Services (IDS) Pharmacy, Baltimore
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 10, 2026 · NCT07733765Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2Healthy volunteers welcome
Ages 12 to 75 · All sexes · Updated Jun 22, 2026 · NCT05398809A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Kindred Hair and Skin Center, Marriottsville
RecruitingPhase 3
Ages 6 to 14 · All sexes · Updated Apr 28, 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- U.S. Dermatology Partners - Rockville, Rockville
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Jan 28, 2026 · NCT07133308From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.